Presidential Document
8 May 2025
epa, pharmaceuticals, fda, supply chain, manufacturing, regulatory relief, domestic production
💊Executive Order for Regulatory Relief in Pharmaceutical Production
Executive Order 14293 emphasizes the necessity of regulatory relief to support the domestic production of essential medicines. It outlines measures to streamline the review processes by key agencies like the FDA and EPA, aiming to eliminate barriers to pharmaceutical manufacturing. The order highlights a strategic initiative to secure a resilient domestic pharmaceutical supply chain and enhance national security.
Learn More